Di-p-toluoyl-L-tartaric acid monohydrate, 98.0%, 1g

Methyl 5-(trifluoromethyl)pyrazine-2-carboxylate, 97%, 100mg

METHYL N-BOC-2-OXOPIPERIDINE-3-CARBOXYLATE, 95.0%, 10g

(S)-1-Methyl-1,2,3,4-tetrahydro-isoquinoline hydrochloride, 97%, 5g

ETHYL 5-BENZOXAZOLECARBOXYLATE, 97.0%, 250mg

Ethyl 1-(4-methoxybenzyl)-1H-1,2,3-triazole-4-carboxylate, 99.0%, 1g

(3-Methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl)methanol, 97%, 2g

(3-Phenyl-1-adamantyl)acetic acid, 95.0%, 250mg

(S)-(-)-2-Methyl-2-propanesulfinamide, min. 98%, 1 g, glass packaging

N,N'-[(1R,2R)-1,2-Diphenyl-1,2-ethanediyl]bis[2-diphenylphosphinobenzamide], 97%, 250mg

(4-(Allyloxy)-2-methylphenyl)methanol, 95%, 2g

(2,4,6-Trichlorophenyl)hydrazine, 98.0%, 100g

Ciprofibrate>98.0%(GC)(T)5g